Is a 160 gene panel that includes assessment of non-coding variants.
Is ideal for patients with a clinical suspicion of inherited susceptibility to cancer. This panel is designed to detect heritable germline mutations and should not be used for the detection of somatic mutations in tumor tissue.
N/A
Not Available